Showing results (571-580 of 9,400) with videos related to
Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|July 1, 2022
Impact of Inflammation on Midazolam Metabolism in Severe COVID-19 PatientsEdouard Charles Le Carpentier, Emmanuel Canet, Damien Masson, et al.Clinical Pharmacology and Therapeutics|January 7, 2021
IL-17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in VigibaseNadine Petitpain, Ferdinando D'Amico, Melissa Yelehe-Okouma, et al.Clinical Pharmacology and Therapeutics|June 18, 2021
Immunopharmacogenomics: Mechanisms of HLA-Associated Drug ReactionsPooja Deshpande, Rebecca J Hertzman, Amy M Palubinsky, et al.Clinical Pharmacology and Therapeutics|July 16, 2021
The Posology of Dupilumab in Pediatric Patients With Atopic DermatitisMohamed A Kamal, Pavel Kovalenko, Matthew P Kosloski, et al.Clinical Pharmacology and Therapeutics|July 7, 2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics StudiesCaitrin W McDonough, Helen R Warren, John R Jack, et al.Clinical Pharmacology and Therapeutics|June 12, 2021
Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA StudyKatja Schlichtig, Pauline Dürr, Frank Dörje, et al.Clinical Pharmacology and Therapeutics|May 22, 2022
Challenges and Opportunities for Improved Drug-Drug Interaction Predictions for Renal OCT2 and MATE1/2-K TransportersSrinivasan Krishnan, Diane Ramsden, Douglas Ferguson, et al.Clinical Pharmacology and Therapeutics|May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium PerspectiveKunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.Clinical Pharmacology and Therapeutics|July 21, 2021
Methadone Destabilizes Cardiac Repolarization During SleepSoroosh Solhjoo, Naresh M Punjabi, Andrada E Ivanescu, et al.Clinical Pharmacology and Therapeutics|May 9, 2022
Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N1 -Methylnicotinamide: A PBPK Modeling ApproachDenise Türk, Fabian Müller, Martin F Fromm, et al.Pageof 940